Mechanistic RBC Partitioning Studies of MLN4924, a Nedd8-Activating Enzyme inhibitor

被引：0
|
作者：
Xia, Cindy Q. [1 ]
Chen, Susan [1 ]
Zhang, Ji [1 ]
Wu, Jing-Tao [1 ]
Qian, Mark G. [1 ]
Lee, Frank W. [1 ]
Balani, Suresh K. [1 ]
机构：
[1] Millennium Pharmaceut Inc, Dmpk, Cambridge, MA USA
来源：
DRUG METABOLISM REVIEWS | 2010年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：94 / 95
页数：2
相关论文
共 50 条
  • [1] A Gatekeeper Residue for NEDD8-Activating Enzyme Inhibition by MLN4924
    Toth, Julia I.
    Yang, Li
    Dahl, Russell
    Petroski, Matthew D.
    [J]. CELL REPORTS, 2012, 1 (04): : 309 - 316
  • [2] The NEDD8-activating enzyme inhibitor MLN4924 reduces ischemic brain injury in mice
    Yu, Huilin
    Luo, Haiyu
    Chang, Luping
    Wang, Shisheng
    Geng, Xue
    Kang, Lijing
    Zhong, Yi
    Cao, Yongliang
    Wang, Ranran
    Yang, Xing
    Zhu, Yuanbo
    Shi, Mei-Juan
    Hu, Yue
    Liu, Zhongwang
    Yin, Xuhui
    Ran, Yunwei
    Yang, Hao
    Fan, Wenying
    Zhao, Bing-Qiao
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (06)
  • [3] Radiosensitization of Human Colorectal Cancer Cells by MLN4924: An Inhibitor of NEDD8-Activating Enzyme
    Wan, Juefeng
    Zhu, Ji
    Li, Guichao
    Zhang, Zhen
    [J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2016, 15 (04) : 527 - 534
  • [4] Discovery of the Nedd8 activating enzyme inhibitor MLN4924
    Langston, Steven P.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [5] Targeting the protein ubiquitination machinery in melanoma by the NEDD8-activating enzyme inhibitor pevonedistat (MLN4924)
    Wong, Kit Man
    Micel, Lindsey N.
    Selby, Heather M.
    Tan, Aik Choon
    Pitts, Todd M.
    Bagby, Stacey M.
    Spreafico, Anna
    Klauck, Peter J.
    Blakemore, Stephen J.
    Smith, Peter F.
    McDonald, Alice
    Berger, Allison
    Tentler, John J.
    Eckhardt, S. Gail
    [J]. INVESTIGATIONAL NEW DRUGS, 2017, 35 (01) : 11 - 25
  • [6] The NEDD8-Activating Enzyme Inhibitor MLN4924 Disrupts Nucleotide Metabolism and Augments the Efficacy of Cytarabine
    Nawrocki, Steffan T.
    Kelly, Kevin R.
    Smith, Peter G.
    Keaton, Mignon
    Carraway, Hetty
    Sekeres, Mikkael A.
    Maciejewski, Jaroslaw P.
    Carew, Jennifer S.
    [J]. CLINICAL CANCER RESEARCH, 2015, 21 (02) : 439 - 447
  • [7] Targeting the protein ubiquitination machinery in melanoma by the NEDD8-activating enzyme inhibitor pevonedistat (MLN4924)
    Kit Man Wong
    Lindsey N. Micel
    Heather M. Selby
    Aik Choon Tan
    Todd M. Pitts
    Stacey M. Bagby
    Anna Spreafico
    Peter J. Klauck
    Stephen J. Blakemore
    Peter F. Smith
    Alice McDonald
    Allison Berger
    John J. Tentler
    S. Gail Eckhardt
    [J]. Investigational New Drugs, 2017, 35 : 11 - 25
  • [8] MLN4924: a novel first-in-class inhibitor of NEDD8-activating enzyme for cancer therapy
    Nawrocki, Steffan T.
    Griffin, Patrick
    Kelly, Kevin R.
    Carew, Jennifer S.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (10) : 1563 - 1573
  • [9] Radiosensitization of Human Pancreatic Cancer Cells by MLN4924, an Investigational NEDD8-Activating Enzyme Inhibitor
    Wei, Dongping
    Li, Hua
    Yu, Jie
    Sebolt, Jonathan T.
    Zhao, Lili
    Lawrence, Theodore S.
    Smith, Peter G.
    Morgan, Meredith A.
    Sun, Yi
    [J]. CANCER RESEARCH, 2012, 72 (01) : 282 - 293
  • [10] Quantifiable analysis of cellular pathway inhibition of a Nedd8-activating enzyme inhibitor, MLN4924, using AlphaScreen
    Yan, Zhong-Hua
    Burkhardt, Anne
    Loke, Huay-Keng
    Chen, Jesse
    Xu, Qing
    Brauer, Pam
    Ma, Jingya
    Lin, Yafang
    Garcia, Khris
    Dick, Lawrence R.
    Bembenek, Michael E.
    [J]. ANALYTICAL BIOCHEMISTRY, 2013, 439 (02) : 109 - 115
12345